基本信息
2,3-二氯-6-三氟甲基-4-硝基甲苯;盐酸氢吗啡酮
Morphinan-6-one,4,5-epoxy-3-hydroxy-17-methyl-, hydrochloride, (5a)- (9CI); Morphinan-6-one, 4,5a-epoxy-3-hydroxy-17-methyl-,hydrochloride (8CI); Morphinone, dihydro-, hydrochloride (6CI);4,5-Epoxy-3-hydroxy-N-methyl-6-oxomorphinan hydrochloride; Dihydromorphinonehydrochloride; Dilaudid; Dilaudid hydrochloride; Hydromorphodone; Hydromorphonehydrochloride; Hymorphan; Laudicon; NSC 117862; Palladone
71-68-1
1S\/C17H19NO3.ClH\/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;\/h2,4,10-11,16,19H,3,5-8H2,1H3;1H\/t10-,11+,16-,17-;\/m0.\/s1
200-762-6
物化属性
2,3-二氯-6-三氟甲基-4-硝基甲苯(71-68-1)为白色或近白色结晶性细粉末,无臭,味苦,溶于水(1:3),难溶于乙醇;几乎不溶于乙醚。注射液PH为3.5~5.5。储存条件:2-8°C溶解度:H2O: >10 mg/mL
其他信息
2,3-二氯-6-三氟甲基-4-硝基甲苯(71-68-1)为吗啡的衍生物,主要作用于μ受体。镇痛效力为吗啡的8倍。用于中度至重度疼痛的止痛,不良反应及依赖潜力同吗啡。
2,3-二氯-6-三氟甲基-4-硝基甲苯(71-68-1)注意事项:注射液有刺激性。可致注射部位疼痛和硬结。危险品运输编号:UN 1230 3/PG 2WGK Germany:3RTECS号:QD2625000HazardClass:6.1(a) PackingGroup:II